212 related articles for article (PubMed ID: 8292489)
1. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
[TBL] [Abstract][Full Text] [Related]
2. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.
Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473
[TBL] [Abstract][Full Text] [Related]
3. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
4. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
5. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
6. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
7. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
9. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
10. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
11. Analysis of recombinant human saposin A expressed by Pichia pastoris.
Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
[TBL] [Abstract][Full Text] [Related]
12. Preparation of the cerebroside sulfate activator (CSAct or saposin B) from human urine.
Fluharty AL; Lombardo C; Louis A; Stevens RL; Whitelegge J; Waring AJ; To T; Fluharty CB; Faull KF
Mol Genet Metab; 1999 Nov; 68(3):391-403. PubMed ID: 10562467
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
14. The cerebroside sulfate activator from pig kidney: purification and molecular structure.
Fluharty AL; Katona Z; Meek WE; Frei K; Fowler AV
Biochem Med Metab Biol; 1992 Feb; 47(1):66-85. PubMed ID: 1562358
[TBL] [Abstract][Full Text] [Related]
15. The activator protein for glucosylceramide beta-glucosidase from guinea pig liver. Improved isolation method and complete amino acid sequence.
Sano A; Radin NS; Johnson LL; Tarr GE
J Biol Chem; 1988 Dec; 263(36):19597-601. PubMed ID: 3198642
[TBL] [Abstract][Full Text] [Related]
16. Porcine cerebroside sulfate activator (saposin B) secondary structure: CD, FTIR, and NMR studies.
Waring AJ; Chen Y; Faull KF; Stevens R; Sherman MA; Fluharty AL
Mol Genet Metab; 1998 Jan; 63(1):14-25. PubMed ID: 9538512
[TBL] [Abstract][Full Text] [Related]
17. Porcine cerebroside sulfate activator: further structural characterization and disulfide identification.
Stevens RL; Faull KF; Conklin KA; Green BN; Fluharty AL
Biochemistry; 1993 Apr; 32(15):4051-9. PubMed ID: 8471613
[TBL] [Abstract][Full Text] [Related]
18. Disulfide connectivity in cerebroside sulfate activator is not necessary for biological activity or alpha-helical content but is necessary for trypsin resistance and strong ligand binding.
Faull KF; Higginson J; Waring AJ; Johnson J; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL
Arch Biochem Biophys; 2000 Apr; 376(2):266-74. PubMed ID: 10775412
[TBL] [Abstract][Full Text] [Related]
19. Selective proteolytic cleavage of recombinant human interleukin 4. Evidence for a critical role of the C-terminus.
Le HV; Seelig GF; Syto R; Ramanathan L; Windsor WT; Borkowski D; Trotta PP
Biochemistry; 1991 Oct; 30(40):9576-82. PubMed ID: 1911743
[TBL] [Abstract][Full Text] [Related]
20. Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Penn B; To T; Johnson J; Waring A; Sherman M; Stevens RL; Fluharty CB; Faull KF; Fluharty AL
Protein Sci; 2000 Sep; 9(9):1618-30. PubMed ID: 11045609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
